Securities Class Action

Securities fraud litigation history and active cases

In Litigation

0

Settlement

0

Closed

1

Total Settlement

$0

MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX) Class Action Lawsuit (June 2018)

Closed

3:18cv1160 • June 4, 2018

Class Period Start

May 12, 2014

Class Period End

September 7, 2018

PSLRA Deadline

August 3, 2018

Case Allegations

10b5

Statutes of Repose

May 12, 2017

Country

United States

Court

Federal Court

Docket History

Nov 13, 2018

Voluntary Dismissal (opens in a new tab)

The plaintiff in this action has chosen not to proceed with the case. Once a case is voluntary dismissed, the courts will usually close the case and no further action will be taken.

Sep 6, 2018

Appointment of Lead Plaintiff (opens in a new tab)

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Jun 4, 2018

First Filed Complaint (opens in a new tab)

A securities fraud class action complaint has been filed on behalf of certain investors in MABVAX THERAPEUTICS HOLDINGS, INC..